Clinical Trial Update: Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update reports safety/side-effect data for first-line treatment of metastatic colorectal cancer using FOLFOXIRI with tocotrienol or placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)
• Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: Vejle Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED